Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

GCS greater than NIHSS baseline and TOAST predicts better outcomes in stroke patients
Cerebrovascular Disease and Interventional Neurology
(-)
119
Authors/Disclosures
Adam Friedant, DO
PRESENTER
Dr. Friedant has nothing to disclose.
Dominique Monlezun, Jr No disclosure on file
Alexander George No disclosure on file
Ramy El Khoury, MD, FÂé¶¹´«Ã½Ó³»­ (Neuro Care of Louisiana) No disclosure on file
Sheryl Martin-Schild, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Dr. Brain, Inc.) No disclosure on file
Michael Strupp, MD, DO, FÂé¶¹´«Ã½Ó³»­ (Hospital of the Ludwig Maximilians University, Munich, Dept of Neurology) Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has or had stock in IntraBio.